Comparative Outcomes Related to Delivery-room Cord Milking In Low-resourced Kountries

NCT03657394 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3442

Last updated 2026-02-13

No results posted yet for this study

Summary

The investigators will conduct a study on non-vigorous infants at birth to determine if umbilical cord milking (UCM) results in lower rate of moderate to severe hypoxic ischemic encephalopathy (HIE) or death than early clamping and for infants who are non-vigorous at birth and need immediate resuscitation.

Conditions

  • Hypoxic-Ischemic Encephalopathy
  • Birth Asphyxia

Interventions

OTHER

Umbilical cord milking

At delivery, the umbilical cord is grasped, and blood is pushed toward the infant 4 times before the cord is clamped. This procedure infuses a placental transfusion of blood into the infant and can be done in 1--15 seconds.

Sponsors & Collaborators

  • Sharp HealthCare

    collaborator OTHER
  • Thomas Jefferson University

    collaborator OTHER
  • University of San Diego

    collaborator OTHER
  • St. Louis University

    collaborator OTHER
  • Jawaharlal Nehru Medical College

    collaborator OTHER
  • Daga Memorial Maternity and Children's Hospital, Nagpur, India

    collaborator UNKNOWN
  • Mahatma Gandhi Institue of Medical Sciences, Wardha, India

    collaborator UNKNOWN
  • Karnataka Institue of Medical Sciences, Hubbali, India

    collaborator UNKNOWN
  • Jawaharlal Institute of Postgraduate Medical Education & Research

    collaborator OTHER_GOV
  • All India Institute of Medical Sciences

    collaborator OTHER
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH
  • Indira Gandhi Government Medical College & Hospital, Nagpur, India

    collaborator UNKNOWN
  • Pimpri Chinchwad Municipal Corporation's Post-Graduate Institute, Yashwantrao Chavan Memorial Hospital, Pune, India

    collaborator UNKNOWN
  • Government Medical College, Nagpur

    collaborator INDUSTRY
  • Nemours Children's Clinic

    lead OTHER

Principal Investigators

  • Zubair H Aghai, MD · Nemours Children's Clinic

  • Anup Katheria, MD · Sharp Mary Birch Hospital for Women & Newborns

  • Sangappa Dhaded, MD · KLE Academy of Higher Education and Research

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
35 Weeks
Max Age
42 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-17
Primary Completion
2025-09-01
Completion
2026-06-28

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03657394 on ClinicalTrials.gov